These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 508663)

  • 41. The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women.
    Cauley JA; Gutai JP; Kuller LH; Powell JG
    Am J Epidemiol; 1990 Nov; 132(5):884-94. PubMed ID: 2239903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. II. Serum lipid levels.
    Behall KM; Moser PB; Kelsay JL; Prather ES
    Am J Clin Nutr; 1980 Apr; 33(4):825-31. PubMed ID: 7361701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic effects of continuous estradiol-progestin therapy in postmenopausal women.
    Sporrong T; Hellgren M; Samsioe G; Mattsson LA
    Obstet Gynecol; 1989 May; 73(5 Pt 1):754-8. PubMed ID: 2704503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of estrogen and progesterone on plasma platelet-activating factor-acetylhydrolase activity and low-density lipoprotein cholesterol concentration in men.
    Ohshige A; Ito M; Koyama H; Maeda T; Yoshimura T; Okamura H
    Artery; 1996; 22(3):115-24. PubMed ID: 8893970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipids.
    Wallentin L; Larsson-Cohn U
    Acta Endocrinol (Copenh); 1977 Nov; 86(3):597-607. PubMed ID: 200045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
    Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
    Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone, 2 mg., and mestranol, 0.1 mg., in polycystic ovarian disease.
    Andersen RN; Givens JR; Wiser WL; Umstot ES
    Am J Obstet Gynecol; 1976 May; 125(2):166-9. PubMed ID: 944533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate.
    Madden JD; Milewich L; Parker CR; Carr BR; Boyar RM; Mac Donald PC
    Am J Obstet Gynecol; 1978 Oct; 132(4):380-4. PubMed ID: 152061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
    Horwitt MK; Harvey CC; Dahm CH
    Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution.
    Berg G; Mesch V; Boero L; Sayegh F; Prada M; Royer M; Muzzio ML; Schreier L; Siseles N; Benencia H
    Horm Metab Res; 2004 Apr; 36(4):215-20. PubMed ID: 15114519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O; Lim P; Caubel P
    Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
    Falkeborn M; Lithell H; Persson I; Vessby B; Naessén T
    Climacteric; 2002 Sep; 5(3):240-8. PubMed ID: 12419082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial.
    Notelovitz M; Feldman EB; Gillespy M; Gudat J
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1269-80. PubMed ID: 2655452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum lipids, arterial blood pressure and body weight in relation to the menopause: results from a population study of women in Göteborg, Sweden.
    Lindquist O; Bengtsson C
    Scand J Clin Lab Invest; 1980; 40(7):629-36. PubMed ID: 7466291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
    Christiansen C; Riis BJ
    Br J Obstet Gynaecol; 1990 Dec; 97(12):1087-92. PubMed ID: 2126198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.